WITHDRAWN: Non-Anti-TNF Biologics as Salvage Therapy for Refractory Acute Severe Ulcerative Colitis, A Systematic Review

Weissman, Simcha; Aziz, Muhammad; Bangolo, Ayrton; Zahdeh, Tamer; Elias, Daniel; Taneja, Vikas; El-Dallal, Mohammed; Nagesh, Vignesh K.; Aleem, Haris; Ghaffar, Umar; Singla, Kushaghar; Thwe, Hla M; Muthukumar, Ananya; Gurumurthy, Vaishnavi; Prasad, Bodapati A; Chugh, Rachita; Mutabi, Erasmus; Kalra, Meenal; Muthineni, Venkata Ab; Khota, Kavya; Gade, Amulya; Thompson-Edwards, Ashley; Venkatesh, Harini K; Jijo, Joseph P; Salib, Yousstina; Ogbu, Chukwuemeka E; Elias, Sameh; Feuerstein, Joseph D.

doi:10.2174/2772432818666230221160937

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results are especially important in the era of biologics, which are widely used in the management of UC, either to induce or maintain remission [ 21 ]. It has been shown in the literature that the use of biologics is associated with the development of MM [ 22 ].…”

Section: Discussionmentioning

confidence: 99%

Association between Multiple Myeloma and Ulcerative Colitis: A Cross-Sectional Analysis

et al. 2023

View full text Add to dashboard Cite

Background and Aims: Multiple myeloma (MM) is a plasma cell dyscrasia that is common among patients with autoimmune diseases. However, the association between ulcerative colitis (UC) and multiple myeloma (MM) is yet to be established. We aimed to evaluate the prevalence of MM among patients with UC in the United States. Methods: This cross-sectional cohort analysis used the National Inpatient Sample from 2015–2018 to assess the overall MM prevalence among patients with and without UC, and within specific demographic subgroups. Prevalences were compared using a logistic regression model controlling for sex and age. Results: The crude prevalence of MM among patients with UC (n = 1750) compared with patients without UC (n = 366,265) was 0.44% vs. 0.37%, respectively. Patients with UC had increased overall odds of having MM (odds ratio (OR), 1.26). Males with UC had higher prevalence of MM (53.7% vs. 46.3%, respectively) than females. Patients with UC and MM were more likely to be African American than White (15.6% vs. 9.2%, respectively). Patients with UC age >64 had a higher prevalence of MM than those aged below 65 (70.9% vs. 29.1%, respectively). Patients with UC who were obese (BMI > 30) had a higher prevalence of MM than those who were non-obese (12.6% vs. 8.3%). Conclusions: Overall, UC appears to be associated with MM. This association can be particularly observed in specific demographic groups, such as obese, African American males, or patients >64 years of age. Thus, a high degree of clinical suspicion for MM is warranted, even with minimal symptomatology, in patients with UC, in particular among elder, obese, and African American males.

show abstract

Section: Discussionmentioning

confidence: 99%